MedPath
HSA Product

THALLOUS CHLORIDE (Tl201) INJECTION 37 MBq/ml

Product approved by Health Sciences Authority (SG)

Basic Information

THALLOUS CHLORIDE (Tl201) INJECTION 37 MBq/ml

INJECTION

Regulatory Information

SIN10153P

September 30, 1998

Prescription Only

Therapeutic

INTRAVENOUS

August 10, 2023

June 4, 2025

XV09GX01

Company Information

QT INSTRUMENTS (S) PTE LTD

QT INSTRUMENTS (S) PTE LTD

Active Ingredients

Detailed Information

Contraindications

**Contraindications** None known.

Indication Information

**Indications** Scintigraphy with thallium-201 is performed to localize, within the healthy myocardium, areas of diminished or no uptake – both at rest and in conjunction with exercise stress testing – and to evaluate the degree of the impairment. Data thus obtained are used to improve the total of diagnostic information about the quality and condition of the myocardium.

© Copyright 2025. All Rights Reserved by MedPath